Your session is about to expire
← Back to Search
Virtual Reality Technology for Head and Neck Cancer
Study Summary
This trial uses virtual reality technology and 3D-surgery modeling to improve current treatments for head and neck cancer. This may improve surgical planning and communication between surgeons and pathologists, and ultimately increase the accuracy of planning and quality of communication for patients with head and neck cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with a type of throat cancer.I am older than 18 years.Anything that could increase your risk or prevent you from fully participating in the study.I am able to understand and make decisions about my health care.You cannot participate if you are already enrolled in another clinical trial.
- Group 1: Arm I (VR/3D-CEPs, standard treatment)
- Group 2: Arm II (standard treatment)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To what extent is the population size of this experiment?
"Affirmative, clinicaltrials.gov indicates that this trial is currently recruiting patients. It was first posted on February 4th 2022 and last updated on August 1st 2022 - it seeks to enroll 40 individuals from one site."
Are researchers currently seeking volunteers for this trial?
"Affirmative. Per the information provided via clinicaltrials.gov, this medical experiment is still recruiting participants after its initial posting on February 4th 2022 and last update on August 1st 2022. The team aims to enrol 40 patients from a single site."
Share this study with friends
Copy Link
Messenger